Abstract 4619: Integrated genomic analysis of Hurthle cell carcinoma reveals TMEM233/PRKAB1 fusion as a novel oncogenic driverYiyu Dong, Timothy A. Chan, James A. Fagin et al.|Cancer Research|2018Cited by 1
Genomic biomarkers of response to nivolumab/ipilimumab (nivo/ipi) and nivolumab (nivo) monotherapy in 108 patients with advanced renal cell carcinoma.Chung‐Han Lee, A. Ari Hakimi, Maria I. Carlo et al.|Journal of Clinical Oncology|2019Cited by 1
MP25-10 GENOMIC BIOMARKERS OF RESPONSE TO NIVOLUMAB/IPILIMUMAB AND NIVOLUMAB MONOTHERAPY IN 108 PATIENTS WITH METASTATIC RENAL CELL CARCINOMARenzo G. DiNatale, A. Ari Hakimi, Chung‐Han Lee et al.|The Journal of Urology|2019Cited by 0